New pill for cystic fibrosis shows promise in early trial
NCT ID NCT05090904
First seen Mar 18, 2026 · Last updated May 22, 2026 · Updated 5 times
Summary
This study tested a new tablet called brensocatib in 29 adults with cystic fibrosis. The goal was to see how the drug behaves in the body and if it is safe compared to a placebo over 4 weeks. Participants had stable lung function and continued their usual treatments.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CYSTIC FIBROSIS are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
USA001
Gainesville, Florida, 32610, United States
-
USA002
St Louis, Missouri, 63101, United States
-
USA003
Tyler, Texas, 75708, United States
-
USA004
Dallas, Texas, 75390, United States
-
USA006
Cleveland, Ohio, 44195, United States
-
USA008
Cleveland, Ohio, 44106, United States
-
USA009
Charleston, South Carolina, 29425, United States
-
USA011
Boston, Massachusetts, 02115, United States
-
USA016
Augusta, Georgia, 30912, United States
-
USA017
Nashville, Tennessee, 37232, United States
-
USA018
Portland, Oregon, 97239, United States
-
USA022
New York, New York, 10032, United States
-
USA023
Ann Arbor, Michigan, 48109, United States
-
USA025
Glenview, Illinois, 60025, United States
Conditions
Explore the condition pages connected to this study.